LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.

Jordan, S C

Clinical and experimental immunology

2021  Volume 204, Issue 3, Page(s) 310–320

Abstract: ... 19 infection. Information regarding innate and adaptive immune responses to the novel severe ... of patients infected with SARS-CoV-2 and the development of novel vaccines. In this paper, data on important ... innate immune responses are summarized, including cytokines, specifically interleukin (IL)-6 and complement, and potential ...

Abstract The factors responsible for the spectrum of coronavirus 19 (COVID-19) disease severity and the genesis and nature of protective immunity against COVID-19 remain elusive. Multiple studies have investigated the immune responses to COVID-19 in various populations, including those without evidence of COVID-19 infection. Information regarding innate and adaptive immune responses to the novel severe respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved rapidly. Data are accumulating defining disease phenotypes that aid in rational and informed development of new therapeutic approaches for the treatment of patients infected with SARS-CoV-2 and the development of novel vaccines. In this paper, data on important innate immune responses are summarized, including cytokines, specifically interleukin (IL)-6 and complement, and potential treatments are explored. Adaptive immune responses and derivative therapeutics such as monoclonal antibodies directed at spike proteins are also examined. Finally, data on real-time assessments of adaptive immune responses are explored, which include CD4
MeSH term(s) Adaptive Immunity ; COVID-19/immunology ; COVID-19 Vaccines/immunology ; Humans ; Immunity, Humoral ; Immunity, Innate ; Interleukin-6/metabolism ; SARS-CoV-2/physiology ; T-Lymphocytes/immunology ; Vaccine Potency
Chemical Substances COVID-19 Vaccines ; Interleukin-6
Language English
Publishing date 2021-03-04
Publishing country England
Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID 218531-3
ISSN 1365-2249 ; 0009-9104 ; 0964-2536
ISSN (online) 1365-2249
ISSN 0009-9104 ; 0964-2536
DOI 10.1111/cei.13582
Shelf mark
Zs.B 337: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top